AVADEL PHARMACEUTICALS (AVDL) Stock Analyst Ratings
USA - NASDAQ:AVDL - IE00BDGMC594 - Common Stock
23.075 USD
+0.13 (+0.59%)
ChartMill assigns a Buy % Consensus number of 70% to AVDL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.83. This target is -14.05% below the current price.
AVDL was analyzed by 16 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about AVDL.
In the last month the buy percentage fell by 13 points. So the trust of analysts is decreasing.
AVDL was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-28 | UBS | Downgrade | Buy -> Neutral |
| 2025-10-23 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-10-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-10-22 | Needham | Downgrade | Buy -> Hold |
| 2025-10-22 | Jefferies | Downgrade | Buy -> Hold |
| 2025-09-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-03 | Wells Fargo | Initiate | Equal-Weight |
| 2025-08-21 | UBS | Maintains | Buy -> Buy |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-04 | Needham | Reiterate | Buy -> Buy |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | Needham | Reiterate | Buy -> Buy |
| 2025-02-11 | Deutsche Bank | Initiate | Buy |
| 2025-01-13 | UBS | Maintains | Buy -> Buy |
| 2025-01-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-09 | Needham | Maintains | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-12 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-18 | Needham | Reiterate | Buy -> Buy |
| 2024-09-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-29 | Needham | Reiterate | Buy -> Buy |
AVADEL PHARMACEUTICALS / AVDL FAQ
What do analysts expect the price target to be for AVADEL PHARMACEUTICALS (AVDL)?
16 analysts have analysed AVDL and the average price target is 19.83 USD. This implies a price decrease of -14.05% is expected in the next year compared to the current price of 23.075.
How do analysts rate AVADEL PHARMACEUTICALS (AVDL)?
The consensus rating for AVADEL PHARMACEUTICALS (AVDL) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.